Form 4: Hanover Bancorp CFO Granted Restricted Stock

Sentiment:

Insider Transaction Report


Hanover Bancorp's SEVP & CFO, Lance P. Burke, received a grant of 3,185 restricted common shares vesting over three years.

Summary

  • Lance P. Burke, the Senior Executive Vice President and Chief Financial Officer of Hanover Bancorp, Inc. (HNVR), was granted 3,185 shares of common stock.
  • The transaction date for this grant was February 5, 2026.
  • The shares were granted at a price of $0.0000, indicating a restricted stock award.
  • Following this transaction, Mr. Burke beneficially owns 29,142 shares of common stock.
  • The grant represents restricted stock subject to forfeiture, with vesting occurring over a three-year period.
  • One-third of the granted shares will vest on March 1, 2027, another third on March 1, 2028, and the final third on March 1, 2029.
  • The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term shareholder interests and aid in executive retention.

Positives

  • The restricted stock grant aligns the interests of the Chief Financial Officer with those of shareholders, as the value of the award is tied to the company's stock performance.
  • The multi-year vesting schedule acts as a retention incentive for a key executive, promoting stability in leadership.
  • The grant is part of a pre-arranged 10b5-1 plan, indicating a structured approach to executive compensation and reducing concerns about opportunistic timing.

Negatives

  • The issuance of new shares for compensation, even restricted, can lead to minor dilution for existing shareholders upon vesting, though this is a standard practice.

Risks

  • The restricted stock is subject to forfeiture, meaning Mr. Burke could lose the unvested shares if certain conditions (e.g., continued employment) are not met.
  • The value of the compensation is tied to the future performance of Hanover Bancorp's stock, exposing the executive to market risk.

Future Outlook

The future outlook for this specific grant involves the vesting of shares over a three-year period, with one-third of the 3,185 restricted shares vesting annually on March 1, 2027, March 1, 2028, and March 1, 2029.

Industry Context

StockSavvy.ai notes that restricted stock grants with multi-year vesting schedules are a common and widely accepted practice in the banking and financial services industry for executive compensation. This method is favored for its ability to align executive incentives with long-term shareholder value creation and to serve as a strong retention tool for key personnel.

Comparison to Industry Standards

  • The structure of this restricted stock grant, including its vesting schedule, is consistent with typical executive compensation packages observed across the U.S. financial sector.
  • Many regional banks and financial institutions utilize similar equity-based awards to incentivize and retain senior management, often tying vesting to continued service or performance metrics.
  • The use of a Rule 10b5-1 plan for this grant is also a standard corporate governance practice, demonstrating a pre-planned and transparent approach to insider transactions, similar to practices at peers like Bank of America or JPMorgan Chase for their executive compensation programs.

Stakeholder Impact

  • Shareholders: Potential for minor dilution upon vesting, but also benefits from increased alignment of executive interests with long-term company performance.
  • Employees: No direct impact mentioned, but a stable executive team can contribute to overall company stability.
  • Management (Lance P. Burke): Receives equity compensation, subject to forfeiture, providing a significant incentive for continued performance and tenure.

Next Steps

  • One-third of the granted restricted shares will vest on March 1, 2027.
  • Another one-third of the granted restricted shares will vest on March 1, 2028.
  • The final one-third of the granted restricted shares will vest on March 1, 2029.

Key Dates

DateDescription
02/05/2026Transaction date for the restricted stock grant to Lance P. Burke.
02/07/2026Date the Form 4 filing was signed by Lance P. Burke.
03/01/2027First vesting date for one-third of the restricted stock grant.
03/01/2028Second vesting date for one-third of the restricted stock grant.
03/01/2029Third and final vesting date for one-third of the restricted stock grant.

Recommendation

hold

This Form 4 filing reports a routine, pre-planned restricted stock grant to a key executive as part of their compensation. While positive for executive retention and alignment, it does not present new information that would fundamentally alter the investment thesis or warrant a change in an investor's current position. It is a standard corporate action.

Keywords

Hanover Bancorp, HNVR, Restricted Stock Grant, Executive Compensation, Insider Transaction, Form 4, Lance P. Burke, CFO, Stock Award, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.